The genetic susceptibility literature suggests that individuals with GJB2 or mitochondrial mutations are more vulnerable to environmental and pharmacological insults, which aligns with findings in cancer survivors exposed to cisplatin [28,52,56]. This evidence concerns the gene GJB2 and cancer.